Literature DB >> 20204286

RNA interference-mediated hTERT inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells.

Ru-Gang Zhang1, Jing-Jing Zhao, Liu-Qin Yang, Shi-Ming Yang, Rong-Quan Wang, Wen-Sheng Chen, Gui-Yong Peng, Dian-Chun Fang.   

Abstract

TRAIL has been reported to induce apoptosis in a variety of tumor cell types including hepato-cellular carcinoma (HCC) cell lines. However, considerable numbers of HCC cells, especially some highly malignant tumors, show resistance to TRAIL-induced apoptosis. The molecular mechanisms that regulate sensitivity versus resistance of tumor cells to TRAIL-induced apoptosis remain poorly defined. It has been shown that human telomerase catalytic subunit (hTERT) is overexpressed in human HCCs. In this study, we investigated the effects and the mechanisms of hTERT RNAi on the TRAIL-induced apoptosis of HCC cells that exhibit resistance to TRAIL. Our results indicate that hTERT RNAi sensitizes TRAIL-resistant HCC cells to TRAIL-induced apoptosis. hTERT RNAi-mediated sensitization to TRAIL-induced apoptosis is accompanied up-regulation of procaspases-8 and -9, inhibition of telomerase activity and loss of telomere length. Our results suggest that hTERT RNAi overcame the resistance of the HCC cells against TRAIL, at least in part, via the mitochondrial type II apoptosis pathway and telomerase-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20204286     DOI: 10.3892/or_00000727

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Role of telomerase reverse transcriptase in glial scar formation after spinal cord injury in rats.

Authors:  Xu Tao; Yang Ming-Kun; Sheng Wei-Bin; Guo Hai-Long; Kan Rui; Tu Lai-Yong
Journal:  Neurochem Res       Date:  2013-06-22       Impact factor: 3.996

2.  miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.

Authors:  L Chen; M-H Lü; D Zhang; N-B Hao; Y-H Fan; Y-Y Wu; S-M Wang; R Xie; D-C Fang; H Zhang; C-J Hu; S-M Yang
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

3.  A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.

Authors:  Venturina Stagni; Simonetta Santini; Daniela Barilà
Journal:  Cancers (Basel)       Date:  2012-04-05       Impact factor: 6.639

Review 4.  Involvement of DNA damage response pathways in hepatocellular carcinoma.

Authors:  Sheau-Fang Yang; Chien-Wei Chang; Ren-Jie Wei; Yow-Ling Shiue; Shen-Nien Wang; Yao-Tsung Yeh
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

5.  Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor‑related apoptosis‑inducing ligand‑induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.

Authors:  Xin Zhao; Cuicui Zhang; Zhiliang Le; Suyun Zeng; Chaobin Pan; Jianjie Shi; Jianguang Wang; Xiaopeng Zhao
Journal:  Int J Mol Med       Date:  2018-06-07       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.